维普期刊资源整合服务平台（V6.5）

83篇 您的检索式：作者名="GREEN BD"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	Estimating the mortality effect of the July 2006 California heat wave 显示文摘	Ostre BD Roth LA Green RS	2009	Environ Res2009，109，：	1
2	Direct and indirect effects of obestatin peptides on food intake and the regulation of glucose homeostasis and insulin secretion in mice 显示文摘	Green BD Irwin N Flatt PR	2007	Peptides2007，28，5：	1
3	Solution-grown zinc oxide nanowires显示文摘	LE Greene BD Yuhas M Law	2006	Inorganic Chemistry2006，45，：	1
4	Solid-state laser synthet- ic aperture radar 显示文摘	Marcus S Colella BD Green JTJ	1994	Applied Optics1994，33，6：	1
5	Direct and indirect effects of obestatin peptides on food intake and the regulation of glucose homeostasis and insulin secretion in mice显示文摘	Green BD Irwin N Flatt PR	2007	Peptides2007，28，5：	1
6	Novel glucagon-like peptide-1(GLP-1)analog(Val8)GLP-1 results in significant improvements of glucose tolerance and pancreaticβ-cell function after 3-week daily administration in obese diabetic(ob/ob)mice显示文摘	Green BD Lavery KS Irwin N	2006	J Pharracol Exp Ther2006，318，2：	1
7	Inhibition of dipeptidase-Ⅳ activity by metformin enhance the antidiabetic effects of glucagon like peptide-1 显示文摘	Green BD Irrwin N Dully NA	2006	Eur J Pharmacol2006，547，13：	1
8	N-acetyl-GLP-1:a DPP IV-resistant analogue of glucagon-like peptide-1 (GLP-1) with improved effects on pancreatic beta-cell-associated gene expression显示文摘	Liu HK Green BD Gault VA	2004	Cell Biol Int2004，28，1：	1
9	Development and ther-apeutic potential of incretin hormone analogues for type 2diabetes 显示文摘	Green BD Irwin N Gault VA	2005	The British Journal of Diabetes and VascularDisease2005，5，3：	1
10	Lys9 for Glu9 substitution in glucagon-like peptide-1 ( 7 - 36 ) amide confers dipeptidylpeptidase IV resistance with cellular and metabolic actions similar to those of established antagonists glucagon-like peptide-1 (9 - 36) amide and exendin ( 9 - 39 ) 显示文摘	Green BD Mooney MH Gauh VA	2004	Metabolism2004，53，2：	1
11	Structurally modi-fied analogues of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) as fu-ture antidiabetic agents显示文摘	Gault VA O'harte FP	2004	Curr Pharm Des2004，10，29：	1
12	N-terminal His(7)-modification of glucagon-like peptide-1 (7-36) amide generates dipeptidyl peptidase Ⅳ-stable analogues with potent antihyperglycaemie activity显示文摘	Mooney MH Gault VA	2004	Journal of En-docrinology2004，180，3：	1
13	Long-term administration of PACAP receptor antagonist PACAP (6-27), impairs glucose tolerance and insulin sensitivity in obese diabetic ob/ob mice 显示文摘	Green BD Irwin N Cassidy RS	2006	Peptides2006，27，9：	1
14	Structually modified ana- logues of glucagon-like peptide-1 ( GLP-1 ) and glucose-depend- ent insalinotropic polypeptide(GIP) as future antidiabetic agents 显示文摘	Green BD Gauh VA O'harte FP	2004	Curr pharm Des2004，10，29：	1
15	Aktl is the principal Akt isoform regulating apoptosis in limiting cytokine concentrations显示文摘	Green BD Jabbour AM Sandow JJ	2013	Cell Death Differ2013，20，10：	1
16	Chemical ablation of gastric inhibitory polypeptide receptor action by daily ( Pro 3 ) GIP administration improves glucose tolerance and ameliorates insulin resist- ance and abnormalities of islet structure in obesityrelated diabetes 显示文摘	Gauh VA h'win N Green BD	2005	Diabetes2005，54，8：	1
17	GLP-1and related peptides cause concentration dependent relaxation of rat aorta through a pathway involving KATP and cAMP显示文摘	Green BD H K Dougan JE McDonnell BM r2 al	2008	Arch Biochem Biophys2008，478，2：	1
18	The relationship between human epidermal growthlike factor receptor expression and cellular transformation in NIH3T3 cells显示文摘	Cohent BD Kiener PA Green JM	1996	J Biol Chem1996，271，30：	1
19	Structurally modified analogues of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) as future antidiabetic agents显示文摘	Green BD Gault VA O'harte FP	2004	Curr Pharm Des2004，10，29：	1
20	Novel glucagon-like peptide-1 (GLP-1) analog (Val8)GLP-1 results in significant improvements of glucose tolerance and pancreatic β-cell function after 3-week daily administration in obese diabetic (ob/ob) mice显示文摘	Green BD Levary KS Nigel Irwin	2006	J Pharmacol Exp Ther2006，318，2：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示